BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16611029)

  • 21. Current status of artemisinin and its derivatives as antimalarial drugs.
    Dhingra V; Vishweshwar Rao K; Lakshmi Narasu M
    Life Sci; 2000; 66(4):279-300. PubMed ID: 10665980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxicity of ethanolic extracts of Artemisia annua to Molt-4 human leukemia cells.
    Singh NP; Ferreira JF; Park JS; Lai HC
    Planta Med; 2011 Nov; 77(16):1788-93. PubMed ID: 21674435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artesunate reduces chicken chorioallantoic membrane neovascularisation and exhibits antiangiogenic and apoptotic activity on human microvascular dermal endothelial cell.
    Huan-huan C; Li-Li Y; Shang-Bin L
    Cancer Lett; 2004 Aug; 211(2):163-73. PubMed ID: 15219940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Potentials and Mechanisms of Artemisinin and its Derivatives for Tumorigenesis and Metastasis.
    Li Y; Zhou X; Liu J; Yuan X; He Q
    Anticancer Agents Med Chem; 2020; 20(5):520-535. PubMed ID: 31958040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artemisinin and its derivatives: an important new class of antimalarial agents.
    Balint GA
    Pharmacol Ther; 2001; 90(2-3):261-5. PubMed ID: 11578659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artemisinin induces apoptosis in human cancer cells.
    Singh NP; Lai HC
    Anticancer Res; 2004; 24(4):2277-80. PubMed ID: 15330172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines.
    Efferth T; Oesch F
    Biochem Pharmacol; 2004 Jul; 68(1):3-10. PubMed ID: 15183112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and antitumor activity of novel artemisinin derivatives using hybrid approach.
    Xie L; Zhai X; Ren L; Meng H; Liu C; Zhu W; Zhao Y
    Chem Pharm Bull (Tokyo); 2011; 59(8):984-90. PubMed ID: 21804243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phytochemical regulation of the tumor suppressive microRNA, miR-34a, by p53-dependent and independent responses in human breast cancer cells.
    Hargraves KG; He L; Firestone GL
    Mol Carcinog; 2016 May; 55(5):486-98. PubMed ID: 25789847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-angiogenic properties of artemisinin derivatives (Review).
    Wei T; Liu J
    Int J Mol Med; 2017 Oct; 40(4):972-978. PubMed ID: 28765885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.
    Chen HH; Zhou HJ; Wu GD; Lou XE
    Pharmacology; 2004 May; 71(1):1-9. PubMed ID: 15051917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dihydroartemisinin: A Potential Natural Anticancer Drug.
    Dai X; Zhang X; Chen W; Chen Y; Zhang Q; Mo S; Lu J
    Int J Biol Sci; 2021; 17(2):603-622. PubMed ID: 33613116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of an Artemisia annua herbal preparation and identification of active ingredients.
    Lang SJ; Schmiech M; Hafner S; Paetz C; Steinborn C; Huber R; Gaafary ME; Werner K; Schmidt CQ; Syrovets T; Simmet T
    Phytomedicine; 2019 Sep; 62():152962. PubMed ID: 31132755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Genome of Artemisia annua Provides Insight into the Evolution of Asteraceae Family and Artemisinin Biosynthesis.
    Shen Q; Zhang L; Liao Z; Wang S; Yan T; Shi P; Liu M; Fu X; Pan Q; Wang Y; Lv Z; Lu X; Zhang F; Jiang W; Ma Y; Chen M; Hao X; Li L; Tang Y; Lv G; Zhou Y; Sun X; Brodelius PE; Rose JKC; Tang K
    Mol Plant; 2018 Jun; 11(6):776-788. PubMed ID: 29703587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro.
    Chen HH; Zhou HJ; Fang X
    Pharmacol Res; 2003 Sep; 48(3):231-6. PubMed ID: 12860439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artemisinin and its derivatives: a potential treatment for leukemia.
    Lam NS; Long X; Wong JW; Griffin RC; Doery JCG
    Anticancer Drugs; 2019 Jan; 30(1):1-18. PubMed ID: 30540593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones.
    Ren Y; Yu J; Kinghorn AD
    Curr Med Chem; 2016; 23(23):2397-420. PubMed ID: 27160533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in chemical constituents of Artemisia annua L from different geographical regions in China.
    Zhang X; Zhao Y; Guo L; Qiu Z; Huang L; Qu X
    PLoS One; 2017; 12(9):e0183047. PubMed ID: 28880869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and cytotoxicity of artemisinin derivatives containing cyanoarylmethyl group.
    Wu JM; Shan F; Wu GS; Li Y; Ding J; Xiao D; Han JX; Atassi G; Leonce S; Caignard DH; Renard P
    Eur J Med Chem; 2001 May; 36(5):469-79. PubMed ID: 11451535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells.
    Berdelle N; Nikolova T; Quiros S; Efferth T; Kaina B
    Mol Cancer Ther; 2011 Dec; 10(12):2224-33. PubMed ID: 21998290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.